Nearly half of patients with chronic hepatitis D virus (HDV) infection treated with bulevirtide achieved the combined primary endpoint of reduced or undetectable HDV RNA levels and normalized alanine ...

This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the eighth installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...

Hepatitis D Virus (HDV) Particle. Image Made According To A View Under Transmission Electron Microscope, Viral Diameter 35 Nm. This is the first part of a series on hepatitis D virus, a virusoid-like ...

The World Health Organization (WHO) has reclassified Hepatitis D as carcinogenic to humans, placing it in the same league as Hepatitis B and C—both already known for causing liver cancer. According to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Up to 57% of patients with chronic hepatitis D virus ...

Please provide your email address to receive an email when new articles are posted on . Patients with HIV and hepatitis B coinfection are at an increased risk for hepatitis D. Patients with hepatitis ...

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...

A new review published on JAMA Network discusses the magnitude of the current hepatitis D virus (HDV) epidemic and its implications for public health. HDV is a small ribonucleic acid (RNA) virus that ...

Treatment with the investigational drug bulevirtide plus pegylated interferon alfa-2a (PegIFNα) resulted in more patients achieving undetectable levels of hepatitis D virus (HDV) RNA compared with ...

DelveInsight's Chronic Hepatitis D Market Insights report includes a comprehensive understanding of current treatment practices, chronic hepatitis D emerging drugs, market share of individual ...

Vir Biotechnology may be pushing ahead with its combination therapy in hepatitis D, but it's pausing further development in hepatitis B while it seeks a suitable partner. Back in November, Vir arrived ...

Hepatitis is an inflammation of the liver. It’s considered acute until it lasts six months, at which point it’s considered chronic. Complications that can develop from chronic hepatitis include a ...